Table 3.
Clinic visit attendance among smoking cessation clinical trial participants by last in-person visit for the pre–COVID-19 cohort (n=51).
| Matching in-person visita | n | On-site clinic visit completion, n (%)b | On-site visit attendance (%) | |||||
|
|
|
Visit #2 | Visit #3 | Visit #4 | Visit #5 | Visit #6 |
|
|
| Visit #1 | 11 | 11 (100) | 11 (10) | 10 (91) | 10 (91) | 8 (73) | 91 | |
| Visit #2 | 9 | N/Ac | 7 (78) | 7 (78) | 7 (78) | 7 (78) | 78 | |
| Visit #3 | 14 | N/A | N/A | 14 (100) | 14 (100) | 13 (93) | 98 | |
| Visit #4 | 7 | N/A | N/A | N/A | 6 (86) | 6 (86) | 86 | |
| Visit #5 | 10 | N/A | N/A | N/A | N/A | 10 (100) | 100 | |
| Total | 51 | 11 (100) | 18 (90) | 31 (91) | 37 (93) | 44 (86) | 89.8d | |
aMatching: on-site visit during a similar period in 2018 and 2019.
bPercentages in the Total row are calculated based on the sum of visits in each column.
cN/A: not applicable.
d95% CI 84.0%-94.1%.